Researchers developed a rapid, non-invasive, point-of-care platform for the direct detection of SARS-CoV-2 in exhaled breath.
Real-World Data Reassure Advanced NSCLC Patients Stopping Immunotherapy at Two years
Credit: Peter Dazeley/ Getty Images Findings by researchers from the University of Pennsylvania should reassure patients and clinicians that stopping immunotherapy for advanced non-small-cell lung